Our study shows that the IC50s for GTN in the Bcl-2 stable transfectants ranged from 26 μM to 33 μM and were not significantly different from the control values, confirming that the oncoprotein Bcl-2 did not confer resistance to GTN cytotoxicity. The gene discussed is BCL2; the disease is gestational trophoblastic neoplasm.